Abiopharma

Xenetic Biosciences, Inc. Announces Adjournment of 2025 Annual Meeting

Travere Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Xenetic Biosciences, Inc. Announces Adjournment of 2025 Annual Meeting

The Joint Corp. Signs Asset Purchase Agreement to Sell 22 Corporate Clinics in the Southeast and Delivers Notice to Terminate APA for 45 Clinics in California

Notification from BriaCell Therapeutics Corp.

Enliven Therapeutics Reports Inducement Grants as Permitted by the Nasdaq Listing Rules

UTHR: Notification

UTHR: Notification

Zoetis - Zoetis Declares First Quarter 2026 Dividend; Board Approves 6% Payment Increase

Zoetis Declares First Quarter 2026 Dividend; Board Approves 6% Payment Increase